Recently, Nanjing Sunway Biomedical Technology Co., Ltd. was awarded by the International Notified Body.BSI British Standards Institute in the United States, Brazil, Australia, Canada and Japan under the special regulations issued by the five countries MDSAP system certificate.Single Audit Scheme for Medical DevicesThe MEDICAL DEVICE SINGLE AUDIT PROGRAM(MDSAP) is an international project initiated by the Committee of Regulators of the International Medical Device Regulatory Forum IMDRF, which aims at medical device manufacturers to pass an audit by an MDSAP-accredited audit organization.Meet the quality management system requirements of different countries.

As a front-end enterprise in the field of blood transfusion, Nanjing Sunway Biology focuses on the research and development, production and sales of medical devices in the two main industries of safe blood transfusion and wound treatment."Safety and efficiency for the purpose, to the international level as the goal" quality policy. Our company's quality system is based on ISO13485 standards and is established in combination with the regulatory requirements of the corresponding countries and regions in our target market.

This acquisitionThe MDSAP quality system certificate is the result of our company's emphasis on system regulations for many years. It is a far-reaching measure for our company to go international and establish the Shuangwei brand. It will also bring advantages and convenience to the access of our products in overseas markets. It is conducive to opening the door to more target markets and further accelerating the company's pace of going international. Let's forge ahead and start again. Shuangwei Biology will continue to use advanced blood transfusion technology and high quality products to shine in the world!